COMPANY
Valencia Technologies
Timeline
- Trial start Not phased (device or behavioral study): Effectiveness of eCoin at Sensory and Subsensory Amplitudes source ↗
- Trial start Not phased (device or behavioral study): A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE) source ↗
- Trial start Not phased (device or behavioral study): eCoin for OAB Feasibility Follow-on Study source ↗
- Trial start Not phased (device or behavioral study): Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence source ↗
- Trial start Not phased (device or behavioral study): eCoin Tibial Nerve Stimulation for OAB source ↗
- Trial start Not phased (device or behavioral study): Subcutaneous Median Nerve Neuromodulation For Drug-Treatment Resistant Hypertension. source ↗
Upcoming milestones
- 2027-03 (ESTIMATED) · Not phased · A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE) · NCT05685433
Clinical trials (lead sponsor) 6
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05685433 | A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE) | Not phased (device or behavioral study) | Recruiting | Jan 26, 2023 | 2027-03 (estimated) |
| NCT05882318 | Effectiveness of eCoin at Sensory and Subsensory Amplitudes | Not phased (device or behavioral study) | Completed | Jun 6, 2023 | Apr 19, 2024 (actual) |
| NCT03556891 | Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence | Not phased (device or behavioral study) | Completed | Sep 4, 2018 | Apr 12, 2020 (actual) |
| NCT03655054 | eCoin for OAB Feasibility Follow-on Study | Not phased (device or behavioral study) | Completed | Mar 13, 2019 | Jan 31, 2020 (actual) |
| NCT03029624 | eCoin Tibial Nerve Stimulation for OAB | Not phased (device or behavioral study) | Completed | Apr 3, 2017 | Dec 30, 2017 (actual) |
| NCT02926495 | Subcutaneous Median Nerve Neuromodulation For Drug-Treatment Resistant Hypertension. | Not phased (device or behavioral study) | Withdrawn | 2016-11 | 2018-05 (estimated) |